Science 37   Report issue

For profit Phase 1 Phase 3
Founded: Los Angeles CA United States (2014)

Organization Overview

First Clinical Trial
2016
NCT02832063
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Science 37

Active Ingredients

Drugs in Phase 3 Trials (1)

b244 (1 trial)

Drugs in Phase 1 Trials (1)

nb01 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2